Mike Nolte, CEO talks about Signant’s new brand and the importance of bringing empathy into clinical trials at DIA 2019 with PharmaVOICE.
Other content in this Stream
Happy Holidays from Signant Health
We’ve put together a little video to spread some holiday cheer from our family to yours. Happy Holidays from Signant Health.
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA
Q&A with Katie Garner, Signant Health: Using eCOA in Ulcerative Colitis Trials for Seamless MAYO Score Calculation
Signant Health Unveiled at DIA 2019
DIA 2019 Recap by Signant Health.
Electronic Version of the Neurostatus-EDSS Improves MS Trials
University Hospital Basel, Novartis and Signant Health (formerly CRF Health) recently published our experience data on the use of the eEDSS obtained from two phase III Multiple Sclerosis trials.
Patient-Centric Technology in Clinical Trials: A Recap
A recap of our inaugural CRF Bracket Patient-Centric Technology in Clinical Trials roadshow in Boston.
Different, Not Less: Why We Need to Ensure Clinical Research is Patient-Driven
In honor of Autism Awareness Month, we spoke with Brian Catton, PharmD, who he sheds light on Autism and awareness surrounding the disorder.
Leveraging Technology to Develop New Trial Endpoints
Technology is enabling us to provide richer insights and potentially measure new meaningful constructs in clinical trials that we have been unable to assess robustly in the past.
Leveraging Today's Gaming For Better Health Reported Outcomes Tomorrow - ICDVRAT 2018
Researchers from across the world collaborated to review work developing applications using immersive and mobile technologies as clinical treatment options, or as a means of objectively measuring and
Seven Ways eCOA will Improve Your CNS Clinical Trials
Capturing Clinical Outcomes Assessments in CNS studies can be difficult due to the unique patient populations in this therapeutic area. eCOA has emerged as the preferred method of capturing patient da
Must Read Book for Researchers Implementing ePRO
This book is intended to provide information on the successful design and implementation of electronic patient-reported outcomes (ePRO / eCOA) in pharmaceutical clinical trials and clinical research.
Simplifying the Implementation of Electronic Patient-Reported Outcomes - Applied Clinical Trials
There have been a number of significant scientific and regulatory milestones driving the adoption of electronic patient-reported outcomes (ePRO) in clinical trials since 1980.
Game Technology Opens New Path to Clinical Endpoints - DIA Podcast
Dr. Bill Byrom, VP of Product Strategy & Innovation at CRF Health discusses the future of electronic patient reported outcomes (ePRO), mobile accelerometry, & other mobile devices, in clinical trials.
Preparing for eConsent - A Step by Step Guide for Site Personnel
5 steps to help sites prepare for implementing an electronic informed consent (eConsent) solution.
Patient-Centric Research Involving Patients in Clinical Trials Can Lead to Better Outcomes
Reducing Patient Challenges of Data Collection During Oncology Clinical Trials
10 Steps for Successful Migration of COA from Paper to Electronic
Benefits of a Combined eCOA/eConsent Solution
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!